MelaTech turns fungal melanin into next-generation materials that protect against radiation.
MelaTech has raised $150K in total funding. The most recent round was Grant. The last funding was announced in July 2024.
MelaTech's investors include Antares Capital, NASA, U.S. Army Combat Capabilities Development Command DEVCOM Soldier Center, Comcast RISE, Maryland Department of Housing and Community Development.
MelaTech is headquartered in Baltimore, United States.
MelaTech turns fungal melanin into next-generation materials that protect against radiation.
MelaTech is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MelaTech — Funding & Investors." VCBacked, July 22, 2024, https://www.vcbacked.co/company/melatech-baltimore. Accessed October 21, 2026.
VCBacked. (2024). MelaTech — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/melatech-baltimore
{{cite web |title=MelaTech — Funding & Investors |url=https://www.vcbacked.co/company/melatech-baltimore |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated